BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33914873)

  • 1. Animal Models of COVID-19 II. Comparative Immunology.
    Veenhuis RT; Zeiss CJ
    ILAR J; 2021 Dec; 62(1-2):17-34. PubMed ID: 33914873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis.
    Zeiss CJ; Compton S; Veenhuis RT
    ILAR J; 2021 Dec; 62(1-2):35-47. PubMed ID: 33836527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Models of COVID-19.
    Caldera-Crespo LA; Paidas MJ; Roy S; Schulman CI; Kenyon NS; Daunert S; Jayakumar AR
    Front Cell Infect Microbiol; 2021; 11():792584. PubMed ID: 35096645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
    Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 immunity in animal models.
    Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J
    Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice.
    Choi S; Lee J; Kim S; Lee YW; Kim GC; Hong SM; An SH; Noh H; Kim KE; On D; Lee SG; Jang HJ; Kim SH; Kim J; Seo JS; Kim JJ; Park IH; Oh J; Kim DJ; Yoon JH; Seok SH; Lee YJ; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Park JW; Yun JW; Shin JS; Seo JY; Nam KT; Choi KS; Kwon HK; Lee HY; Kim JK; Seong JK
    EBioMedicine; 2024 Jan; 99():104932. PubMed ID: 38118400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
    Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
    mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review.
    Runft S; Färber I; Krüger J; Krüger N; Armando F; Rocha C; Pöhlmann S; Burigk L; Leitzen E; Ciurkiewicz M; Braun A; Schneider D; Baumgärtner L; Freisleben B; Baumgärtner W
    Vet Pathol; 2022 Jul; 59(4):565-577. PubMed ID: 35130766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Meta-Analysis of Rhesus Macaques (
    Witt AN; Green RD; Winterborn AN
    Comp Med; 2021 Oct; 71(5):433-441. PubMed ID: 34588096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
    Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
    Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2.
    Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS
    Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.
    Chan CEZ; Seah SGK; Chye H; Massey S; Torres M; Lim APC; Wong SKK; Neo JJY; Wong PS; Lim JH; Loh GSL; Wang D; Boyd-Kirkup JD; Guan S; Thakkar D; Teo GH; Purushotorman K; Hutchinson PE; Young BE; Low JG; MacAry PA; Hentze H; Prativadibhayankara VS; Ethirajulu K; Comer JE; Tseng CK; Barrett ADT; Ingram PJ; Brasel T; Hanson BJ
    PLoS One; 2021; 16(6):e0253487. PubMed ID: 34161386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.
    Kim YI; Yu KM; Koh JY; Kim EH; Kim SM; Kim EJ; Casel MAB; Rollon R; Jang SG; Song MS; Park SJ; Jeong HW; Kim EG; Lee OJ; Kim YD; Choi Y; Lee SA; Choi YJ; Park SH; Jung JU; Choi YK
    Nat Commun; 2022 Jan; 13(1):21. PubMed ID: 35013229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.
    Cameron MJ; Kelvin AA; Leon AJ; Cameron CM; Ran L; Xu L; Chu YK; Danesh A; Fang Y; Li Q; Anderson A; Couch RC; Paquette SG; Fomukong NG; Kistner O; Lauchart M; Rowe T; Harrod KS; Jonsson CB; Kelvin DJ
    PLoS One; 2012; 7(9):e45842. PubMed ID: 23029269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.